Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Xellia Delivering Reliable Anti-Infective Solutions Through Expertise, Quality, and Uninterrupted Global Supply.
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
Pharm-Rx is a reputed global importer and distributor of pharmaceutical active ingredients.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.
Sumar Biotech work together to Innovate & Manufacture Semi-synthetic, Synthetic & Fermentation API.
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Diphtheria Toxoid; Tetanus Toxoid; Bordetella Pertussis Antigen; Inactivated Poliovirus Types 1, 2, 3; Diphtheria Toxoid; Tetanus Toxoid; Bordetella Pertussis Antigen; Inactivated Poliovirus Types 1, 2, 3; Polymyxin B; Haemophilus Influenzae Type B Polysaccharide Conjugated With Tetanus Toxoid; Pertussis Fimbriae
Brand Name : Adacel-Polio
Dosage Form : Suspension For Injection
Dosage Strength :
Packaging :
Approval Date : 26/08/2022
Application Number : 68110
Regulatory Info : Allowed
Registration Country : Switzerland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG ...DOSAGE - OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
USFDA APPLICATION NUMBER - 50065
DOSAGE - OINTMENT;TOPICAL - 400 UNITS/GM;1%;E...DOSAGE - OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50168
DOSAGE - CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/G...DOSAGE - CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50218
DOSAGE - OINTMENT;OPHTHALMIC - 400 UNITS/GM;E...DOSAGE - OINTMENT;OPHTHALMIC - 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM
USFDA APPLICATION NUMBER - 50417
DOSAGE - SOLUTION/DROPS;OPHTHALMIC - 10,000 U...DOSAGE - SOLUTION/DROPS;OPHTHALMIC - 10,000 UNITS/ML;EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50567
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Minbiotech
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gloria Interchem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nippon Fine Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Coating Systems & Additives
Topical
Solubilizers
Parenteral
Thickeners and Stabilizers
Emulsifying Agents
Controlled & Modified Release
Film Formers & Plasticizers
Surfactant & Foaming Agents
Fillers, Diluents & Binders
Direct Compression
Granulation
API Stability Enhancers
Lubricants & Glidants
Empty Capsules
Vegetarian Capsules
Co-Processed Excipients
Taste Masking
Chewable & Orodispersible Aids
Coloring Agents
Rheology Modifiers
Disintegrants & Superdisintegrants
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
21
PharmaCompass offers a list of Polymyxin B Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Polymyxin B Sulfate manufacturer or Polymyxin B Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Polymyxin B Sulfate manufacturer or Polymyxin B Sulfate supplier.
A DEXASPORIN-2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DEXASPORIN-2, including repackagers and relabelers. The FDA regulates DEXASPORIN-2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DEXASPORIN-2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DEXASPORIN-2 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A DEXASPORIN-2 supplier is an individual or a company that provides DEXASPORIN-2 active pharmaceutical ingredient (API) or DEXASPORIN-2 finished formulations upon request. The DEXASPORIN-2 suppliers may include DEXASPORIN-2 API manufacturers, exporters, distributors and traders.
click here to find a list of DEXASPORIN-2 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A DEXASPORIN-2 DMF (Drug Master File) is a document detailing the whole manufacturing process of DEXASPORIN-2 active pharmaceutical ingredient (API) in detail. Different forms of DEXASPORIN-2 DMFs exist exist since differing nations have different regulations, such as DEXASPORIN-2 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DEXASPORIN-2 DMF submitted to regulatory agencies in the US is known as a USDMF. DEXASPORIN-2 USDMF includes data on DEXASPORIN-2's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DEXASPORIN-2 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DEXASPORIN-2 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The DEXASPORIN-2 Drug Master File in Japan (DEXASPORIN-2 JDMF) empowers DEXASPORIN-2 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the DEXASPORIN-2 JDMF during the approval evaluation for pharmaceutical products. At the time of DEXASPORIN-2 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of DEXASPORIN-2 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DEXASPORIN-2 Drug Master File in Korea (DEXASPORIN-2 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DEXASPORIN-2. The MFDS reviews the DEXASPORIN-2 KDMF as part of the drug registration process and uses the information provided in the DEXASPORIN-2 KDMF to evaluate the safety and efficacy of the drug.
After submitting a DEXASPORIN-2 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DEXASPORIN-2 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DEXASPORIN-2 suppliers with KDMF on PharmaCompass.
A DEXASPORIN-2 CEP of the European Pharmacopoeia monograph is often referred to as a DEXASPORIN-2 Certificate of Suitability (COS). The purpose of a DEXASPORIN-2 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of DEXASPORIN-2 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of DEXASPORIN-2 to their clients by showing that a DEXASPORIN-2 CEP has been issued for it. The manufacturer submits a DEXASPORIN-2 CEP (COS) as part of the market authorization procedure, and it takes on the role of a DEXASPORIN-2 CEP holder for the record. Additionally, the data presented in the DEXASPORIN-2 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the DEXASPORIN-2 DMF.
A DEXASPORIN-2 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. DEXASPORIN-2 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of DEXASPORIN-2 suppliers with CEP (COS) on PharmaCompass.
A DEXASPORIN-2 written confirmation (DEXASPORIN-2 WC) is an official document issued by a regulatory agency to a DEXASPORIN-2 manufacturer, verifying that the manufacturing facility of a DEXASPORIN-2 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting DEXASPORIN-2 APIs or DEXASPORIN-2 finished pharmaceutical products to another nation, regulatory agencies frequently require a DEXASPORIN-2 WC (written confirmation) as part of the regulatory process.
click here to find a list of DEXASPORIN-2 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing DEXASPORIN-2 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for DEXASPORIN-2 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture DEXASPORIN-2 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain DEXASPORIN-2 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a DEXASPORIN-2 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of DEXASPORIN-2 suppliers with NDC on PharmaCompass.
DEXASPORIN-2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DEXASPORIN-2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right DEXASPORIN-2 GMP manufacturer or DEXASPORIN-2 GMP API supplier for your needs.
A DEXASPORIN-2 CoA (Certificate of Analysis) is a formal document that attests to DEXASPORIN-2's compliance with DEXASPORIN-2 specifications and serves as a tool for batch-level quality control.
DEXASPORIN-2 CoA mostly includes findings from lab analyses of a specific batch. For each DEXASPORIN-2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DEXASPORIN-2 may be tested according to a variety of international standards, such as European Pharmacopoeia (DEXASPORIN-2 EP), DEXASPORIN-2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DEXASPORIN-2 USP).
